|Daily Range||$54.29 - $56.58|
|52-Week Range||$14.51 - $61.17|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||384,505|
|Current FY EPS||-$3.22|
PTC Therapeutics, Inc. (PTCT) Description
PTC Therapeutics, Inc. Website: http://www.ptcbio.com/
News & Commentary
Taking a look back at the past year reveals some investing lessons you can use in the future.
PTC Therapeutics Starts Rolling NDA Filing for Translarna - Analyst Blog
PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular Dystrophy
Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?